Ischaemic Stroke
Conditions
Brief summary
This study aims to establish a multicenter, large-scale, prospective cohort of patients with ischemic stroke. Various biological samples such as blood, feces, and urine are collected to identify biomarkers associated with ischemic stroke. By integrating demographic information, clinical indicators, imaging parameters, and biomarker parameters, the study aims to develop risk assessment, early warning, and prognosis prediction models. Additionally, the study aims to identify key genes and explore relevant signaling pathways related to ischemic stroke.
Interventions
Intravenous thrombolysis with alteplase within the time window of stroke onset in stroke patients
Sponsors
Xiangya Hospital of Central South University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
1. Clinical diagnosis of ischemic stroke. 2. Age ≥ 18 years. 3. Signed informed consent form.
Exclusion criteria
1. Patients with moderate to severe mental disorders or dementia who cannot cooperate to complete the informed consent and follow-up procedures. 2. Patients with neurological functional impairment caused by conditions such as migraine aura, epilepsy, or other non-ischemic strokes. 3. Agitated patients who cannot cooperate with imaging examinations. 4. Pregnant or lactating patients, as well as those planning to become pregnant within 90 days. 5. Patients with concurrent malignant tumors or severe systemic diseases with an expected survival period of less than 90 days. 6. Patients who have participated in other clinical studies within 30 days prior to enrollment or are currently participating in other interventional clinical studies.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cerebrovascular events | 3 months of onset in patients | Cerebrovascular events, including ischemic stroke, transient ischemic attack, cerebral hemorrhage, subarachnoid hemorrhage |
| mRS scores | 3 months of onset in patients | Assessing patients' neurological functional impairment status using the mRS score |
Countries
China
Outcome results
None listed